Research

Medical Sciences

Title :

A phase III, randomized, double-blind, placebo controlled trial to evaluate the efficacy & safety of Vpm 1002 & immuvac vaccones in preventing Tuberculosis (TB) in healthy household contacts of newly diagnosed sputum positive pulmonary TB patients

Area of research :

Medical Sciences

Focus area :

Task Force (TF)

Principal Investigator :

Ms. N. Wadhwa, Associate Professor, Translational Health Science & Technology Institute, Haryana

Timeline Start Year :

2019

Timeline End Year :

2023

Details

Total Budget (INR):

89,15,650

Organizations involved